Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


IoM Supplement Monograph Framework Should Reflect “Real World” – CFSAN

This article was originally published in The Tan Sheet

Executive Summary

Monographs created under IoM's Framework for Evaluating the Safety of Dietary Supplements should serve as templates for FDA or industry to use in crafting their own ingredient monographs, rather than requiring a comprehensive literature review, Center for Food Safety & Applied Nutrition reps said

You may also be interested in...

Ephedra “Black Box” Warning Considered By FDA

FDA is suggesting that a "black box" warning appear on the principal display panel of all ephedrine alkaloid-containing dietary supplements, FDA Commissioner Mark McClellan, MD/PhD, said during a Feb. 28 briefing held in Washington, D.C

Melatonin, Chromium Monograph Human Safety Data Should Be Used – CRN

Animal and in vitro studies are not useful in crafting safety monographs for melatonin and chromium picolinate because there is adequate human data available, according to Council for Responsible Nutrition VP-Nutritional & Regulatory Science John Hathcock, PhD

Three-Step Supplement Safety Review Model Proposed by IoM

Outside review organizations could play a key role in preparing dietary supplement safety monographs as part of the Institute of Medicine's Proposed Framework for Evaluating the Safety of Dietary Supplements


Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts